
    
      This study is a prospective, interventional, randomized, controlled, paired eye,
      subject-masked design.

      Subjects will be randomly assigned to which eye will receive the Omega Refractive capsule V
      with an FDA approved intraocular lens. Fellow eyes will serve as controls and receive an FDA
      approved IOL (no Omega capsule).
    
  